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Xing Fu‡, Mei-Jun Zhu§, Mike V. Dodson‡, and Min Du‡1
From the ‡Department of Animal Sciences and Department of Pharmaceutical Sciences, Washington Center for Muscle Biology
and the §School of Food Sciences, Washington State University, Pullman, Washington 99164
Background: The mechanisms eliciting metabolic activation in satellite cells are unclear.
Results: Noncanonical Sonic Hedgehog is activated following muscle injury, which activates AMPK␣1 to induce Warburg-like
glycolysis and promote satellite cell activation and proliferation.
Conclusion: AMPK␣1 is required for Warburg-like glycolysis in satellite cells, which promotes satellite cell activation and
muscle regeneration.
Significance: AMPK promotes satellite cell activation during muscle regeneration.
Satellite cells are the major myogenic stem cells residing
inside skeletal muscle and are indispensable for muscle regeneration. Satellite cells remain largely quiescent but are rapidly
activated in response to muscle injury, and the derived myogenic cells then fuse to repair damaged muscle fibers or form
new muscle fibers. However, mechanisms eliciting metabolic
activation, an inseparable step for satellite cell activation following muscle injury, have not been defined. We found that a noncanonical Sonic Hedgehog (Shh) pathway is rapidly activated in
response to muscle injury, which activates AMPK and induces a
Warburg-like glycolysis in satellite cells. AMPK␣1 is the dominant AMPK␣ isoform expressed in satellite cells, and AMPK␣1
deficiency in satellite cells impairs their activation and myogenic differentiation during muscle regeneration. Drugs activating noncanonical Shh promote proliferation of satellite cells,
which is abolished because of satellite cell-specific AMPK␣1
knock-out. Taken together, AMPK␣1 is a critical mediator linking noncanonical Shh pathway to Warburg-like glycolysis in satellite cells, which is required for satellite activation and muscle
regeneration.

Skeletal muscle is the main component in animal locomotion
system. It is also the major tissue sustaining respiration and the
primary peripheral tissue utilizing glucose and fatty acids,
important in preventing obesity and type 2 diabetes (1–3). Skeletal muscle fibers are frequently damaged during exercise and
because of physical trauma or diseases such as Duchenne muscular dystrophy (4, 5). Efficient regeneration following muscle
injury is critical for maintaining the normal physiological function of skeletal muscle. On the other hand, insufficient muscle
regeneration replaces muscle fibers with fibrotic tissue and

weakens the contractile function of muscle, which is a key etiological factor leading to progressive muscle weakness associated with aging and muscle dystrophic diseases (6 – 8).
Despite the presence of multiple types of myogenic cells in
skeletal muscle, satellite cells are the major postnatal myogenic
cells indispensable for muscle regeneration (9). Satellite cells
maintain in a quiescent stage and become activated when muscle regeneration process is triggered (10, 11). Activated satellite
cells proliferate to expand their population and undergo further
myogenic differentiation orchestrated by sequential expression
of myogenic regulatory factors, Myf5, MyoD, myogenin, and
MRF4 (12).
Recent studies show that stem cells including satellite cells
rely on glycolysis to provide energy (13, 14), likely because of
their limited access to oxygen because of deep location in the
tissue and the need to prevent the damage from reactive oxygen
species (15–17). Satellite cells have relatively small cytoplasm
and few mitochondria (10, 18), resulting in low metabolic rates.
However, metabolism of stem cells rapidly elevates during wakening from their quiescent state, providing energy needed for
stem cell proliferation and further differentiation (10). Warburg glycolysis is a primarily source of energy for certain cancer
cells, which allows their fast proliferation (19, 20). Cancer cells
and stem cells share metabolic similarity, and recently, Warburg-like glycolysis was identified in induced stem cells (21).
Moreover, a Warburg-like glycolysis was discovered in differentiated C2C12 myotubes and brown fat (22).
AMP-activated kinase (AMPK)2 is a master regulator of
metabolism that has an ␣ catalytic subunit with two isoforms,
␣1 and ␣2 (23). Here, we report that AMPK␣1 is the dominant
isoform in satellite cells, and AMPK ␣1 mediates Warburg-like
glycolysis needed for satellite cell activation following muscle
injury. Consequently, satellite cell-specific AMPK␣1 KO
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impairs muscle regeneration, characterized by reduced satellite
cell activation and muscle structure restoration.

Experimental Procedures
Mice—All animals were handled in accordance with protocols approved by the Animal Use and Care Committees of
Washington State University. Wild-type C57BL/6 mice, B6.129SPax7tm1(cre/ERT2)Gaka/J mice (catalog no. 017763) in which
tamoxifen-inducible Cre recombinase is driven by the endogenous mouse Pax7 promoter, B6(Cg)-Prkaa1tm1.1Sjm/J mice
(catalog no. 014141) in which AMPK␣1 exon 3 was flanked by
two loxP sites, and Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J
mice (catalog no. 007576) in which a membrane-targeted tdTomato is floxed and EGFP is expressed when cross-bred to Cre
recombinase-expressing mice, were obtained from Jackson
Laboratory (Bar Harbor, ME). B6.129S-Pax7tm1(cre/ERT2)Gaka/J
mice were cross-bred with Prkaa1tm1.1Sjm/J mice to generate
tamoxifen-inducible satellite cell-specific AMPK␣1 KO mouse
strain (Pax7cre/AMPK␣1fl/fl). Pax7cre/AMPK␣1fl/fl mice were
cross-bred with Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J
mice to generate tamoxifen-inducible satellite cell-specific
AMPK␣1 KO mouse strain with tamoxifen-inducible satellite cellspecific EGFP expression (Pax7Cre/AMPK␣1fl/fl/tdtomato,EGFP).
Antibodies and Chemicals—Antibodies against AMPK␣
(antibody 2532), and phospho-AMPK␣ at Thr-172 (antibody
2535), rabbit anti-Ki67 Alexa Fluor 488 (antibody 11882), rabbit anti-PFKFB3 (antibody 13123), rabbit anti-phospho-AMPK
substrate motif (antibody 5759), goat anti-mouse Alexa Fluor
555 (antibody 4409), and goat anti-rat Alexa Fluor 488 (antibody 4416) were purchased from Cell Signaling (Danvers, MA).
Anti-embryonic myosin heavy chain (F1.652), anti-Pax7
(PAX7), anti-MHC (MF20), and anti-␤-tubulin (E7) mouse
monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank (Iowa City, IA). Rabbit antiAMPK␣1 antibody (ABIN737886) and rabbit anti-AMPK␣2
(ABIN680458) antibody were obtained from AntibodiesOnline Inc. (Atlanta, GA). Mouse anti-MyoD antibody
(sc32758), smoothened agonist (SAG), and cyclopamine
were purchased from Santa Cruz (Dallas, TX). Rat antilaminin antibody (4H8-2) was purchased from Enzo (Faringdale, NY). Goat anti-mouse IgG1 Alexa Fluor 555
(A-21127) was purchased from Life Technologies Inc. IRDye
800CW goat anti-rabbit secondary antibody and IRDye 680
goat anti-mouse secondary antibody were purchased from
LI-COR Biosciences (Lincoln, NE). Cardiotoxin, tamoxifen
and Oil-Red O were purchased from Sigma. Basic FGF2
(233-FB-025) and anti-mouse integrin ␣7 APC was purchased from R&D Systems (Minneapolis, MN). Anti-mouse
CD45 PE-Cy7, anti-mouse CD16/CD32, and flow cytometry
buffer were purchased from eBioscience (San Diego, CA).
Anti-mouse TER-119 PE-Cy7, anti-mouse Sca-1 APC-Cy7,
and anti-mouse CD31 PE-Cy7 antibodies were purchased
from BioLegend (San Diego, CA). Gill’s hematoxylin (catalog
no. 26030-10) and Eosin Y-Phloxine B (catalog no. 26051-21)
were purchased from Electron Microscopy Sciences (Hatfield, PA). AICAR was purchased from Toronto Research
Chemicals (Toronto, Canada).
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Fluorescence-activated Cell Sorting—Tibialis anterior (TA)
muscle was digested in DMEM with collagenase D and dispase
II as previously described (24). Cells were blocked in antimouse CD16/CD32 antibody and then stained with anti-mouse
CD45 PE-Cy7, anti-mouse TER119 PE-Cy7, anti-mouse CD31
PE-Cy7, anti-mouse Sca-1 APC-Cy7, and anti-mouse integrin
␣7 APC antibodies. Stained cells were sorted on FACSaria (BD
Biosciences, San Jose, CA) and analyzed by FlowJo (Treestar,
Inc., San Carlos, CA). Gates were made based on fluorescence
minus one control.
Cell Culture—Satellite cells were resuspended in F-10
medium with 20% FBS, 1% antibiotic mixture and 5 ng/ml
FGF2, and seeded on collagen-coated plates. Myogenic differentiation of satellite cells was induced by switching medium to
DMEM supplemented with 2% horse serum and 1% antibiotic
mixture. Nonmyogenic cells were cultured in DMEM with 10%
FBS and 1% antibiotic mixture.
Satellite Cell Proliferation Essay—Satellite cells were isolated
as previously described (25) with modifications. Muscle was
removed from the hind limbs of 3– 4-month-old mice. Muscle
was cut into small pieces and digested in digestion buffer containing collagenase D and dispase II for about 30 min. Muscle
slurry was passed through a 100-m cell strainer. Filtrate was
centrifuged for 5 min at 350 ⫻ g. Cell pellet was resuspended
and cultured in F-10 medium with 20% FBS, 5 ng/ml FGF2, and
1% antibiotic mixture on collagen-coated plates. Satellite cells
were enriched by preplating. Fast attaching nonmyogenic cells
were also collected. Five thousand satellite cells were seeded in
each well of 12 well plates. Cells were then trypsinized and
counted at 1, 2, and 3 days after to determine the cell proliferation rate.
Single Muscle Fiber Culture—Single muscle fibers were isolated as previously described (26) with modification. The extensor digitorum longus muscle was removed from 1-month-old
Pax7Cre/AMPK␣1fl/fl/tdtomato,EGFP and Pax7Cre/tdtomato,
EGFP mice that had been treated with tamoxifen. Extensor
digitorum longus muscle was digested in digestion buffer containing collagenase D. Extensor digitorum longus muscle was
then carefully flushed to release single muscle fibers. Intact single muscle fibers were then transferred to 24-well plates with
one muscle fiber in each well and cultured in high glucose
DMEM with 20% FBS, 5 ng/ml FGF2, 110 mg/ml sodium pyruvate, and 1% antibiotic mixture.
Glucose Uptake Test—Glucose uptake test was performed
using glucose uptake cell base assay kit from Cayman (Ann
Arbor, MI) following the manufacturer’s protocol. The cells
were seeded onto 96-well plates at a density of 1 ⫻ 104 cells/
well. Cells were cultured with fluorescently labeled deoxyglucose analog, and fluorescence was detected using Synergy H1
hybrid reader (BioTek, Winooski, VT).
Real Time Quantitative PCR—Total RNA was extracted
using TRIzol (Sigma) followed by DNase (New England BioLabs Inc., Ipswich, MA) treatment, and cDNA was synthesized
using a reverse transcription kit (Bio-Rad). Real time PCR was
carried out using CFX real time PCR detection system (BioRad) with a SYBR Green real time PCR kit from Bio-Rad. After
amplification, a melting curve (0.01 °C/s) was used to confirm
product purity, and agarose gel electrophoresis was performed
VOLUME 290 • NUMBER 44 • OCTOBER 30, 2015
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FIGURE 1. Dominant expression of AMPK␣1 in satellite cells. A, AMPK␣1 mRNA expression during WT satellite cell proliferation and differentiation by real
time PCR. B, AMPK␣1 and AMPK␣2 mRNA expression in WT quiescent satellite cell isolated from uninjured muscle, WT activated satellite cells isolated from
injured muscle, and isolated WT satellite cells at 3 days of myogenic differentiation. C, IHC staining detecting AMPK␣2 in regenerating TA muscle from WT mice
at 7 days after CTX injection combined with laminin or Pax7 IHC staining. Scale bars, 200 m. D, IHC staining detecting AMPK␣1 in uninjured TA muscle and
regenerating TA muscle from WT mice at 3 days after CTX injection combined with Pax7 staining. Scale bars, 100 m. E, IHC staining detecting p-AMPK␣ in
uninjured TA muscle and regenerating TA muscle from WT mice at 3 days after CTX injection combined with Pax7 staining. Scale bars, 100 m. MG, myogenic
differentiation. The magnified images of areas marked by solid yellow lines are shown in the corners of corresponding pictures outlined by dotted sline. **, p ⬍
0.01; ***, p ⬍ 0.0001 versus control; means ⫾ S.D.; n ⱖ 3.

to confirm that only a single product of the right size was amplified. Relative mRNA content was normalized to 18S rRNA content (24). Primer sequences and their respective PCR fragment
lengths are listed below. 18S rRNA (110 bp), forward 5⬘-TGCTGTCCCTGTATGCCTCT-3⬘ and reverse 5⬘-TGTAGCCACGCTCGGTCA-3⬘; Pax7 (115 bp), forward 5⬘-TTGGGGAACACTCCGCTGTGC-3⬘ and reverse 5⬘-CAGGGCTTGGGAAGGGTTGGC-3⬘; MyoD (100 bp), forward 5⬘-TCTGGAGCCCTCCTGGCACC-3⬘ and reverse 5⬘-CGGGAAGGGGGAGAGTGGGG-3⬘; Myf5 (125 bp), forward 5⬘-AAACTCCGGGAGCTCCGCCT-3⬘ and reverse 5⬘-GGCAGCCGTCCGTCATGTCC3⬘; Myogenin (97 bp), forward 5⬘-GAGATCCTGCGCAGCGCCAT-3⬘ and reverse 5⬘-CCCCGCCTCTGTAGCGGAGA-3⬘;
Smo (121 bp) forward 5⬘-GGCCTGACTTTCTGCGTTGCACACC-3⬘ and reverse 5⬘-GGGTTGTCTGTTCGCACCAAGG-3⬘;
Shh (182 bp) forward 5⬘-CAGCGGCAGATATGAAGGGAAGA-3⬘ and reverse 5⬘-CAGGCCACTGGTTCATCACAGA-3⬘; Gli1
(188 bp) forward 5⬘-AGGTCTGCGTGGTAGAGGGAA-3⬘ and
reverse 5⬘-GTTGGCTTGGTGGCAAAAGGG-3⬘; Ptch1 (121
bp) forward 5⬘-GCAAGTTTTTGGTTGTGGGTCTCC-3⬘ and
reverse 5⬘-TCTCGACTCACTCGTCCACCAA-3⬘; AMPK␣1
(246 bp) forward 5⬘-TGTCTCTGGAGGAGAGCTATTTGA-3⬘ and reverse 5⬘-GGTGAGCCACAGCTTGTTCTT-3⬘;
and AMPK␣2 (150 bp) forward 5⬘-CAGAAGATTCGCAGTTTAGATGTTGT-3⬘ and reverse 5⬘-ACCTCCAGACACATATTCCATTACC-3⬘.
OCTOBER 30, 2015 • VOLUME 290 • NUMBER 44

Immunoblotting Analyses—Immunoblotting analysis was
performed as previously described using an Odyssey Infrared
Imaging System (LI-COR Biosciences) (27). Band density was
normalized to ␤-tubulin content.
Immunocytochemical Staining—Cells grown on multiple
well plates were fixed in cold methanol for 10 min, permeabilized with 0.1% Triton X-100 for 5 min, blocked with 1% BSA,
and incubated with primary antibodies at 4 °C overnight. Cells
were then stained with corresponding secondary antibodies
(1:1,000) for 1 h. Images were taken using a EVOS microscope.
Immunohistochemical Staining—TA muscle was fixed in
cold 4% paraformaldehyde and frozen in isopentane cooled in
liquid nitrogen. Frozen tissue was sectioned (5–10 m thick).
Sections were heated in citrate buffer for 20 min, blocked in 5%
goat serum in TBS containing 0.3% Triton X-100, and stained
with primary antibodies and corresponding fluorescent secondary antibodies. Sections were then mounted in a mounting
medium containing DAPI (Vector Laboratories, Burlingame,
CA).
Quantification of Satellite Cells and EMH⫹ Muscle Fibers—
Pax7⫹ cells with nuclei identified by DAPI staining were classified as satellite cells. For each TA muscle sample, the number
of satellite cells and EMH⫹ muscle fibers on four randomly
picked microscopic fields of each of three sections at different
depths of the muscle were counted (four fields/section, three
sections/muscle). Average numbers obtained from the three
JOURNAL OF BIOLOGICAL CHEMISTRY
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examined sections of each muscle sample were used as a biological replicate for comparative analysis.
Hemotoxylin Staining—TA muscle frozen sections were
rinsed in PBS, stained with Gill’s hemotoxylin, and counterstained with eosin Y following the manufacturer’s protocol.
L-Lactate Assay—Ten thousand cells were seeded in each
well of 96-well plates. 24 h after seeding, cell culture medium
was collected and tested for lactate content using an L-lactate
assay kit from Eton Bioscience, Inc. (San Diego, CA) following
the manufacturer’s instruction.
Oxygen Consumption Assay—200,000 cells were seeded in
each well of 6-well plates. One day after seeding, cell culture
medium was changed with fresh medium. Oxygen content in
medium was measured after 30 min of incubation with Orion
3-Star Pus Dissolved Oxygen Meter (Thermo Scientific, Waltham, MA). Oxygen consumption was calculated from the difference between the oxygen content in medium after 30 min of
incubation and the oxygen content in fresh medium.
Statistics—For all studies, at least three independent experiments were conducted. All data are expressed as means ⫾ S.D.
The data were analyzed using the general linear model of SAS
(SAS Inst. Inc., Cary, NC), and t test or Tukey range test was
used to determine significance of differences among means.
p ⬍ 0.05 was considered significant.

Results
Expression of AMPK␣1 and AMPK␣2 during Skeletal Muscle
Regeneration—To test the role of AMPK␣1 in muscle regeneration, we first measured the expression of AMPK␣1 during the
proliferation and differentiation of isolated satellite cells.
AMPK␣1 expression profoundly increased (⬃6-fold) during
the activation and proliferation of satellite cells. After induction
of myogenesis, the expression of AMPK␣1 dropped first, followed by a slight increase (Fig. 1A), which is consistent with a
previous report showing AMPK␣1 activity in muscle increases
during muscle regeneration, whereas the activity of AMPK␣2
remain unchanged (24, 28). Moreover, AMPK␣1 expression
was consistently and significantly higher than AMPK␣2 in quiescent, activated, and differentiating satellite cells (Fig. 1B).
These data support our hypothesis that AMPK␣1 is important
in activating satellite cell proliferation.
To test whether AMPK␣1 is critical for muscle regeneration
following injury, we analyzed the expression of AMPK␣1 and
AMPK␣2 in TA muscle injured by cardiotoxin (CTX) injection
using immunohistochemical (IHC) staining after injury.
AMPK␣2 was found to be expressed primarily in the cytoplasm
of well differentiated myogenic cells and regenerating muscle
fibers (Fig. 1C). In contrast, AMPK␣1 was found mainly in
mononucleated cells including satellite cells (Fig. 1D). Moreover, we found that AMPK␣1 was also expressed in satellite
cells in uninjured muscle (Fig. 1D). However, p-AMPK␣ was
only detected in satellite cells after injury, indicating AMPK␣1
activation in satellite cells during muscle regeneration, which
might be involved in satellite cell activation and proliferation
(Fig. 1E). These data further suggest that AMPK␣1 has a regulatory role in satellite cell activation, whereas AMPK␣2 plays a
major role in regulating metabolism in differentiated muscle

26448 JOURNAL OF BIOLOGICAL CHEMISTRY

FIGURE 2. Satellite cell-specific KO of AMPK␣1. A and B, ICC staining detecting AMPK␣1 in Lin⫺/Sca-1⫺/integrin ␣7⫹ satellite cells (A) and Lin⫺/Sca-1⫹
cells (B) isolated from tamoxifen-treated AMPK␣1fl/fl (WT) mice and Pax7cre/
AMPK␣1fl/fl (Pax7Cre/AMPK␣1⫺/⫺) mice. C, real time PCR detecting the expression of AMPK␣1 and AMPK␣2 in satellite cells isolated from WT mice and
Pax7Cre/AMPK␣1⫺/⫺ mice. D and E, Western blot detecting the expression of
AMPK␣1 in nonmyogenic cells (D) and satellite cells (E) isolated from muscle
of WT mice and Pax7Cre/AMPK␣1⫺/⫺ mice. *, p ⬍ 0.05; **, p ⬍ 0.01 versus
control; means ⫾ S.D.; n ⱖ 3. Scale bars, 200 m.

fibers. Therefore, we focused further studies on the role of
AMPK␣1 in satellite activation and proliferation.
AMPK␣1 Knock-out Reduces Satellite Cell Proliferation—To
better understand the influence of AMPK␣1 KO on satellite
cell activation and proliferation, we then tested the proliferation of satellite cells isolated from tamoxifen-treated Pax7cre/
AMPKfl/fl mice in which AMPK␣1 gene is specifically deleted in
satellite cells. Satellite cell-specific AMPK␣1 KO was verified
by different assays (Fig. 2, A–E). Indeed, AMPK␣1 KO satellite
cells proliferated slower than WT myoblasts (Fig. 3A). Because
isolated satellite cells lack the niche environment, we further
prepared single muscle fibers from tamoxifen-treated Pax7cre/
tdomato,EGFP mice and Pax7cre/AMPK␣1fl/fl/tdomato,EGFP
mice, in which satellite cells express membrane-located EGFP
upon tamoxifen treatment accompanied with AMPK␣1 KO
specifically in satellite cells. 48 h after muscle fiber isolation,
satellite cells on muscle fibers were compared. Although 38 of
45 observed WT satellite cells had activated and started to proliferate, only 9 of 41 observed AMPK␣1 KO satellite cells
showed sign of proliferation, which suggested less efficient satellite cell activation and proliferation because of AMPK␣1 KO
(Fig. 3B).
Smoothened Agonist Promotes Satellite Proliferation through
Activating AMPK—It has been recently reported that noncanonical Sonic Hedgehog (Shh) signaling promotes a Warburglike glycolysis in differentiated C2C12 myotubes (22). Therefore, we questioned whether this pathway is also present in
undifferentiated myoblasts and satellite cells and whether
AMPK␣1 has a mediatory role in eliciting Warburg-like glycolysis. We first tested the effect of Smoothened (Smo) agonist
VOLUME 290 • NUMBER 44 • OCTOBER 30, 2015
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FIGURE 3. AMPK␣1 KO satellite cells proliferated slower than WT cells in vitro. A, proliferation of satellite cells isolated from tamoxifen-treated AMPK␣1fl/fl
(WT) mice and tamoxifen-treated Pax7cre/AMPK␣1fl/fl mice (AMPK␣1 KO) mice. B, proliferation of satellite cell on single muscle fibers isolated from tamoxifentreated Pax7Cre/tdtomato,EGFP (WT) and tamoxifen-treated Pax7Cre/AMPK␣1fl/fl/tdtomato,EGFP (AMPK␣1 KO) mice at 48 h after isolation. *, p ⬍ 0.05 versus
control; means ⫾ S.D.; n ⱖ 3. Scale bars, 200 m.

FIGURE 4. SAG treatment promotes satellite cell activation and proliferation through AMPK␣1. A, representative Western blot of experiments testing
phosphorylated AMPK (p-AMPK) and total AMPK protein levels in C2C12 with or without 10 min of SAG (200 nM) treatment. B, representative Western blot of
experiments testing phosphorylated AMPK (p-AMPK) and total AMPK protein levels in WT satellite cells with or without 10 min of SAG (200 nM) treatment. C,
L-lactate assay measure L-lactate in culture medium of C2C12 cells, WT satellite cells, and AMPK␣1 (␣1) KO satellite cells with or without 24 h of SAG (200 nM)
treatment. D, proliferation of C2C12 cells, WT satellite cells, and AMPK␣1 (␣1) KO satellite cells during 24 h of culture with or without 24 h of SAG (200 nM)
treatment. E, quantification of GFP⫹ satellite cells in SAG (200 nM) treated and untreated total muscle-resident cells from tamoxifen-treated Pax7Cre/tdtomato,EGFP
mice 48 h after cell isolation. *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍ 0.0001 versus control; means ⫾ S.D.; n ⱖ 3. Scale bars, 200 m.

(SAG), an activator of Shh pathway, on AMPK activity in
C2C12 myoblasts and WT satellite cells. C2C12 myoblasts and
WT satellite cells were treated with 200 nM SAG for only 10 min
OCTOBER 30, 2015 • VOLUME 290 • NUMBER 44

to avoid the activation of canonical Shh signaling (22, 29). In
both C2C12 cells and WT satellite cells, 10 min of SAG treatment activated AMPK (Fig. 4, A and B). L-Lactate assay revealed
JOURNAL OF BIOLOGICAL CHEMISTRY
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increased glycolysis rates in C2C12 cells and WT satellite cells
in response to SAG treatment, which was absent in AMPK␣1
KO satellite cells (Fig. 4C).
In addition, SAG promoted the proliferation of both C2C12
cells and purified WT satellite cells but failed to promote proliferation of purified AMPK␣1 KO satellite cells (Fig. 4D), sug-
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gesting that the proliferative effects of SAG treatment on satellite cells require AMPK␣1. Skeletal muscle contains multiple
cell types that interact with satellite cells and participate in
muscle regeneration (30). To better understand the potential
effect of SAG treatment on satellite cell activation and proliferation in the presence of other cell types, muscle tissue slurry
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FIGURE 6. Activation of AMPK␣1 by AICAR promotes satellite cell activation. A, representative Western blot of experiments testing phosphorylated AMPK
(p-AMPK) and total AMPK protein levels in WT satellite cells with or without 1 h of AICAR (250 M) treatment. B, quantification of GFP⫹ satellite cells in AICAR-treated
(250 M, 1 h) and untreated total muscle-resident cells from muscle of tamoxifen-treated Pax7Cre/tdtomato,EGFP (WT) mice and tamoxifen-treated Pax7Cre/AMPK␣1fl/
fl/tdtomato,EGFP (AMPK␣1 KO) mice 48 h after treatment. C, relative glucose uptake of WT and AMPK␣1 KO satellite cells during 20 of min 250 M AICAR treatment or
control treatment. D, L-lactate assay measure L-lactate in the culture medium of WT satellite cells and AMPK␣1 KO satellite cells treated with AICAR (250 M) or PBS for
24 h. E, oxygen consumption of WT satellite cells during 30 min AICAR (250 M) and control treatments. *, p ⬍ 0.05 versus control; means ⫾ S.D.; n ⱖ 3.

from tamoxifen-treated Pax7cre/tdomato,EGFP mice expressing EGFP in Pax7⫹ cells was obtained by enzymatic digestion of
muscle tissue and plated without sorting. 48 h later, all cells
were harvested, and EGFP-positive satellite cells were quantified. We found that SAG treatment increased the number of
EGFP⫹ satellite cells, further supporting the promotive effect of
Shh signaling on satellite activation and proliferation (Fig. 4E).
Selective Activation of noncanonical Shh Promotes Satellite
Cell Activation and Proliferation—To further test whether the
observed effects of SAG on satellite cells was through noncanonical Shh signaling, WT primary myoblasts were treated
with cyclopamine, a noncanonical Shh specific activator, which
is also known to inhibit canonical Shh (22). 10 min of cyclopamine treatment successfully activated AMPK (Fig. 5A). Considering that noncanonical Shh signaling has relatively rapid
response, we chose to only treat cells for 1 h with low doses of

cyclopamine or SAG so that the impact of canonical Shh signaling on cell proliferation was minimized. Indeed, 1 h of SAG
treatment did not change the expression of the two canonical
Shh targets, Gli1 and Ptch1 (31, 32), in primary myoblasts 24 h
after treatment (Fig. 5B). Similarly, 1 h of cyclopamine treatment did not change the expression of Gli1 and only caused a
slight reduction in Ptch1 expression 24 h after treatment (Fig.
5B). Therefore, fresh muscle tissue slurry from tamoxifentreated Pax7cre/tdomato,EGFP mice and Pax7cre/AMPK␣1fl/fl/
tdomato,EGFP mice with satellite cell-specific AMPK␣1 KO
was treated with SAG and cyclopamine for 1 h in culture
medium. Tissue slurry was then collected and cultured in SAG
and cyclopamine-free medium. SAG and cycolopamine treatments were able to increase the number of EGFP⫹ satellite cells
from Pax7cre/tdomato,EGFP mice at 48 h after treatment but
failed to do so to EGFP⫹ satellite cells without AMPK␣1 (isolated

FIGURE 5. Noncanonical Shh promotes satellite cell activation and proliferation through AMPK␣1. A, representative Western blot of experiments testing
phosphorylated AMPK (p-AMPK) and total AMPK protein levels in WT satellite cells with or without 10 min of cyclopamine (200 nM) treatment. B, real time PCR
showing Gli mRNA expression and Ptch1 mRNA expression 24 h after 1 h of SAG treatment (200 nM) and cyclopamine treatment (200 nM). C, quantification of
GFP⫹ satellite cells in SAG-treated (200 nM, 1 h), cyclopamine-treated (Cyclo, 200 nM, 1 h), and untreated muscle-resident cells from muscle of tamoxifen-treated
Pax7Cre/tdtomato,EGFP (WT) mice and tamoxifen-treated Pax7Cre/AMPK␣1fl/fl/tdtomato,EGFP (AMPK␣1 KO) mice 48 h after treatment. D, proliferation of purified
WT satellite cells, and AMPK␣1 KO satellite cells during 24 h culture following 1 h of 200 nM SAG, 1 h of 200 nM cyclopamine, or vehicle only control treatments.
E, relative glucose uptake of WT and AMPK␣1 KO satellite cells during 20 min of 200 nM SAG treatment, 20 min of 200 nM cyclopamine treatment, or control
treatment. F, oxygen consumption of WT satellite cells during 30 min of 200 nM SAG treatment, 30 min of 200 nM cyclopamine treatment, or control treatment.
G, real time PCR showing Smo mRNA expression at 1, 2, 3, and 4 days after injury. H, representative image of electrophoresis following real time PCR showing
undetected Shh expression in undamaged muscle and in muscle at 1, 2, 3, and 4 days after injury. Day 13.5 mouse embryo was used as a positive control. I, real
time PCR showing Gli mRNA expression and Ptch1 mRNA expression in muscle before injury and at 1, 2, 3, and 4 days after injury. J, L-lactate assay measured
L-lactate content in culture medium of WT and AMPK␣1 KO satellite cells. K, representative Western blot of experiments testing PFKFB3 and phospho-PFKFB3
protein levels in WT and AMPK␣1 KO satellite cells. *, p ⬍ 0.05; **, p ⬍ 0.01 versus control; means ⫾ S.D.; n ⱖ 3.
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FIGURE 7. Satellite cell-specific AMPK␣1 KO attenuated muscle regeneration. Satellite cell-specific AMPK␣1 KO was achieved by tamoxifen-injection of Pax7cre/
AMPK␣1fl/fl mice. TA muscle of tamoxifen-treated AMPK␣1fl/fl (WT) mice and Pax7cre/AMPK␣1fl/fl (Pax7cre/AMPK␣1⫺/⫺) mice were injured by CTX injection. A, hemotoxylin staining of TA muscle at 3 days post injury showing a large quantity of necrotic muscle fibers (#). B and C, Pax7⫹ satellite cells (B) and EMH⫹ muscle fibers (C)
in TA muscle at 3 days post injury and quantification analyzed by IHC staining. D, Lin⫺/Sca-1⫺/integrin ␣7⫹ satellite cells in the TA muscle at 7 days post injury analyzed
by FACS. E, hemotoxylin staining of TA muscle at 7 days post injury showing necrotic muscle fibers (#) and regenerating muscle fibers (*). F and G, Pax7⫹ satellite cells
(F) and EMH⫹ muscle fibers (G) in TA muscle at 7 days post injury and quantification analyzed by IHC staining. H, Pax7, Myf5, MyoD, and myogenin mRNA levels in
muscle at 7 days post injury. dpi, days post injury; KO, Pax7cre/AMPK␣1⫺/⫺. Magnified images of areas marked by solid yellow lines are shown in the corners of
corresponding pictures outlined by dotted lines. *, p ⬍ 0.05; **, p ⬍ 0.01 versus control; means ⫾ S.D.; n ⱖ 3. Scale bars, 200 m.

from tamoxifen-treated Pax7cre/AMPK␣1fl/fl/tdomato,EGFP
mice), indicating an AMPK␣1-dependent stimulatory effect of
noncanonical Shh on satellite cell activation and proliferation
(Fig. 5C). The same treatments were applied to purified satellite
cells. We found that 1-h treatment of SAG and cyclopamine
increased the number of purified WT myoblasts but not that of
AMPK␣1 KO myoblasts, indicating a similar AMPK␣1-dependent stimulatory effect of noncanonical Shh on satellite cell
proliferation (Fig. 5D). Moreover, glucose uptake of WT myoblasts was increased after 20 min of SAG or cyclopamine treatment, but no effect was observed for AMPK␣1 KO myoblasts
(Fig. 5E). In addition, oxygen consumption was not changed in
satellite cells treated with SAG or cyclopamine for 30 min, indicating a specific activation of glycolysis (Fig. 5F).
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To assess the presence of canonical Shh and noncanonical
Shh signaling during muscle regeneration, expression of Shh
and Smo during muscle regeneration was analyzed. Surprisingly, a 30-fold increase in Smo expression was seen during the
first day after muscle injury, showing profound activation of
Shh signaling in the initiation of muscle regeneration, even
though the expression gradually decreased in the following days
(Fig. 5G). In contrast, no Shh expression was detected, which
was not due to technical problems, because a high level of Shh
expression was detected in day 13.5 embryo tissue, a positive
control (Fig. 5H). In addition, the expression of two canonical
Shh targets, Gli1 and Ptch1, dropped dramatically after injury
and remained considerably lower afterward, indicating that
noncanonical but not canonical Shh signaling was active in the
VOLUME 290 • NUMBER 44 • OCTOBER 30, 2015
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FIGURE 8. Reduced myogenic differentiation in satellite cells with AMPK␣1 KO during muscle regeneration. A, IHC co-stained Pax7⫹ and Ki67⫹ cells in
muscle of WT and Pax7cre/AMPK␣1⫺/⫺ mice at 3 days after injury. B, IHC co-stained MyoD⫹ and Ki67⫹ cells in muscle of WT and Pax7cre/AMPK␣1⫺/⫺ mice at 3
days after injury. C, quantification of Pax7⫹/Ki67⫹ cells and MyoD⫹/Ki67⫹ cells in the muscle of WT and Pax7Cre/AMPK␣1⫺/⫺ mice at 3 days after injury. White
arrowhead, MyoD⫹Ki67⫺ cells; yellow arrowhead, MyoD⫹Ki67⫹ cells. Magnified images of area marked by solid yellow lines are shown in the corners of
corresponding pictures outlined by dotted lines. **, p ⬍ 0.01 versus control; means ⫾ S.D.; n ⱖ 3. Scale bars, 200 m.

initiation stage of muscle regeneration (Fig. 5I). The decreased
Smo expression after 2 days post injury likely marked a completion of satellite cell activation and metabolic switch from
glycolysis to oxidative phosphorylation (OXPHOS) during
myogenic differentiation; myogenic differentiation requires
elevated OXPHOS and noncanonical Shh reduces OXPHOS
(22, 33).
Consistently, a reduced glycolytic rate was observed in
AMPK␣1 KO satellite cells compared with WT satellite cells
(Fig. 5J). In addition, we found that 6-phosphofructo-2-kinase/
fructose-2,6-biphosphatase 3 (PFKFB3), an important enzyme
in glycolysis which is activated by AMPK through phosphorylation at Ser-461, was also down-regulated in AMPK␣1 KO
myoblasts (Fig. 5K) (34). PFKFB3 has been reported to regulate
satellite cell proliferation (35). Therefore down-regulated
PFKFB3 might be another hurdle caused by disrupted SmoAMPK axis, which hampered glycolysis and proliferation of
AMPK␣1 KO satellite cells.
Direct Activation of AMPK by AICAR Promoted Satellite Cell
Activation—AICAR, a direct activator of AMPK, was used to
test the effect of AMPK on satellite activation. 1 h of 250 M
AICAR treatment successfully increased AMPK activity in isolated satellite cells (Fig. 6A). Cells were then isolated from
whole muscle tissue of tamoxifen-treated Pax7cre/tdomato,EGFP mice without sorting. 1 h of 250 M AICAR treatment
after cell isolation also increased the number of GFP⫹ satellite
48 h after AICAR treatment (Fig. 6B). However, the same treatment failed to increase the number of GFP⫹ satellite cells isolated from tamoxifen-treated Pax7cre/AMPK␣1fl/fl/tdomato,
EGFP mice, which indicates that direct activation of AMPK␣1
OCTOBER 30, 2015 • VOLUME 290 • NUMBER 44

promotes satellite cell activation. Moreover, 20 min of AICAR
treatment enhanced glucose uptake in WT satellite cells but not
in AMPK␣1 satellite cells (Fig. 6C). Lactate content in culture
medium of WT satellite cells increased by 24-h AICAR treatment, but no difference was found in AMPK␣1 KO satellite
cells treated with AICAR, indicating an enhanced glycolysis in
WT satellite cells mediated by enhanced AMPK␣1 activity (Fig.
6D). In addition, oxygen consumption was not altered in satellite cells treated with AICAR, clearly showing a specific effect of
AICAR treatment on glycolysis (Fig. 6E).
Satellite Cell-specific KO of AMPK␣1 Attenuates Muscle
Regeneration—To better understand the role of AMPK␣1 in
the activation and proliferation of satellite cells during muscle
regeneration while avoiding possible confounding effects of
AMPK␣1 KO on cells other than satellite cells in muscle regeneration, we then employed a tamoxifen-inducible satellite cellspecific AMPK␣1 KO mouse model (Pax7cre/AMPK␣1fl/fl).
CTX was injected to the TA muscle of tamoxifen-treated
AMPK␣1fl/fl mice and Pax7cre/AMPK␣1fl/fl (Pax7Cre/
AMPK␣1⫺/⫺) mice, which showed similar degree of initial
muscle damage (Fig. 7A). However, the number of Pax7⫹ satellite cells and EMH⫹ muscle fibers was reduced in muscle from
Pax7Cre/AMPK␣1⫺/⫺ mice compared with AMPK␣1fl/fl mice
at 3 days post injury (Fig. 7, B and C). Because there was no
difference in satellite cell density before injury, the reduced
number of satellite cells and regenerating muscle fibers suggested attenuation of satellite cell activation and proliferation.
In agreement, in FACS sorting, fewer CD45⫺/TER119⫺/
CD31⫺(Lin⫺)Sca-1⫺/integrin ␣7⫹ satellite cells were present
in muscle from Pax7Cre/AMPK␣1⫺/⫺ mice at 7 days post injury
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(11, 36) (Fig. 7D). Similar differences were observed in IHC
staining (Fig. 7F). Although many newly formed muscle fibers
were present in muscle from AMPK␣1fl/fl mice, a smaller number of newly formed muscle fibers were observed in muscle
from Pax7Cre/AMPK␣1⫺/⫺ mice (Fig. 7, E and G). Consistently,
Pax7, Myf5, MyoD, and myogenin were all expressed lower in
muscle from Pax7Cre/AMPK␣1⫺/⫺ mice at 7 days post injury
compared with AMPK␣1fl/fl mice, indicating a less active muscle regeneration (Fig. 7H).
Moreover, at 3 days post injury, Pax7⫹ satellite cells in both
AMPK␣1fl/fl mice and Pax7Cre/AMPK␣1⫺/⫺ mice were proliferating as indicated by Ki67 expression (Fig. 8, A and C). However, although some MyoD⫹ myoblasts in AMPK␣1fl/fl mice
lost Ki67 expression indicating cell cycle arrest and initiation of
myogenic differentiation, most MyoD⫹ myoblasts in Pax7Cre/
AMPK␣1⫺/⫺ mice remained positive for Ki67, indicating a
delayed myogenic differentiation and a prolonged duration for
proliferation (Fig. 8, B and C). Such a change was likely needed
for compensating the impaired capacity of AMPK␣1 KO myoblasts to proliferate. These data clearly demonstrate that
AMPK␣1 KO negatively affects satellite cell proliferation.

Discussion
Recent studies suggest the importance of metabolic transition in regulating the quiescence, activation, proliferation, and
differentiation of stem cells (14, 15, 37). OXPHOS and glycolysis are two major metabolic pathways generating energy in
mammalian cells (38). OXPHOS is more efficient in generating
energy than glycolysis. However, OXPHOS requires ample oxygen supply and functional mitochondria to be accomplished,
whereas glycolysis does not require oxygen and mainly occurs
in cytoplasm (39). Many stem cells reside deep in tissue where
access to oxygen is very limited (16, 17). Moreover, most quiescent stem cells are relatively small with few immature mitochondria, indicating that glycolysis is a suitable metabolic pathway to supply energy (40 – 42). In addition, glycolysis also
provides intermediates needed for the synthesis of cellular
components for stem cell self-renewal and proliferation such as
nucleotides and lipids (43). On the other hand, overactive
OXPHOS exposes stem cells to reactive oxygen species and in
consequence increases the risk of DNA damage, inducing
mutagenesis and impairing their stemness (15). Because of
these advantages of glycolysis, stem cells mainly relay on glycolysis for energy generation (13, 14). However, the relatively inefficient energy generation of glycolysis poses a challenge for
stem cells to sustain multiple energy demanding processes
associated with stem cell activation and proliferation.
Warburg glycolysis was first discovered in cancer cells (19,
20). It is characterized by enhanced glycolysis even when oxygen is available. Because of the inefficient energy generation of
glycolysis, Warburg glycolysis is associated with dramatically
increased glucose uptake, which provides enough fuel to glycolysis to generate ample energy required for rapid and uncontrolled cell proliferation of cancer cells (44, 45). Cancer cells and
stem cells share similar characteristics including the ability to
rapidly proliferate. Recently, a few studies reported that Warburg-like glycolysis is present in different types of stem cells and
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FIGURE 9. Schematic diagram shows the proposed mechanism for
enhanced satellite cell activation and proliferation by noncanonical Shh
via AMPK␣1 during muscle regeneration. Muscle injury triggers noncanonical Shh pathway in satellite cells, which activates AMPK␣1 and sequentially promotes a Warburg-like glycolysis supporting satellite cell activation
and proliferation. When AMPK␣1 is absent in satellite cells, the proposed
pathway is disrupted, resulting in reduced satellite cell activation and proliferation and the attenuated muscle regeneration.

proliferating nontumor cells to support their energy demand
during proliferation (21, 46, 47).
Satellite cells are adult stem cells residing in skeletal muscle
(48, 49). They stay in a quiescent state with low metabolic rate
under normal conditions (10). However, their activation is rapidly triggered by muscle injury, followed by their proliferation
and differentiation to mediate muscle regeneration (50). During the initial stage of muscle regeneration, satellite cells
involve many rounds of cell proliferation before differentiation
(50). Similar to other stem cells, quiescent satellite cells have
immature mitochondria and a very low metabolic rate, and glycolysis supplies most energy for satellite cells (10, 18). Robust
mitochondria biogenesis and OXPHOS only start when myogenic differentiation is initiated (10, 51). Therefore, there is a
significant demand of energy to support the large biomass formation during satellite cell proliferation before myogenic differentiation. It was recently reported that activation and prolifVOLUME 290 • NUMBER 44 • OCTOBER 30, 2015
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eration of satellite cells are associated with increased glycolytic
metabolism (52). However, it remained unknown how satellite
cells regulate their metabolism to support these processes.
Although it has been shown that AMPK promotes Warburglike glycolysis in C2C12 myotubes, AMPK was shown to suppress Warburg-like glycolysis in certain cancer cells, suggesting
the roles of AMPK in regulating metabolism might vary
depending on cell types (22, 53). Canonical Shh signaling is a
well known signaling pathway promoting myogenic cell proliferation during prenatal myogenesis (54 –56). Our study
revealed the critical role of a distinct noncanonical Shh signaling in muscle regeneration where it promotes satellite cell activation and proliferation during the initiation of muscle regeneration through enhancing glycolysis in satellite cells, a process
mediated by AMPK␣1.
In summary, for the first time, to our knowledge, we showed
that AMPK␣1 is important in muscle regeneration through
mediating noncanonical Shh-triggered Warburg-like glycolysis
in satellite cells, which is required for satellite activation and
proliferation during muscle regeneration (Fig. 9). Because
AMPK activity is attenuated because of a number of pathophysiological conditions such as obesity and type 2 diabetes, and
drugs targeting AMPK are widely available as anti-diabetic
drugs, our data suggest the possibility of applying these drugs to
activate AMPK to facilitate muscle regeneration.
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